TAG:
the clinical laboratory
Lab Automation Pioneer Assesses Outcomes
CEO SUMMARY: Debate has dogged the subject of laboratory automation since its earliest days. That was true during the early 1990s in Japan. It was true in Canada and the United States throughout the 1990s. It is still true in this decade. That is why it was startling to hear a founding fa…
Many Trends in AP Spell Lots of Change Ahead
CEO SUMMARY: Every second year, THE DARK REPORT releases its list of key trends in anatomic pathology. These trends help shape an understanding about the state of the pathology profession. Our current list includes 11 identifiable trends. This is not an auspicious sign for pathologists wh…
Proposed Coding Edits May Restrict 88305 Use
CEO SUMMARY: When the Medicare contractor tasked with developing MUEs (Medically Unbelievable Edits) for this year’s Correct Coding Initiative work released the proposed list of edits to the AMA, it didn’t take long for the bad news to reach the pathology profession. Restriction on un…
Failure of AD Pathlabs: Structural Weakness?
CEO SUMMARY: AD PathLabs is the latest in a string of business disappointments. Over the past decade, a number of anatomic pathology companies have proven that they can grow rapidly—attracting substantial volumes of specimens. But these companies seem to hit a financial wall that leads …
Luminex and PerkinElmer Ink Licensing Agreement
CEO SUMMARY: PerkinElmer’s interest in the multiplex capabilities of Luminex’s xMap technology led to this new licensing agreement. PerkinElmer’s instrument systems played a major role in accelerating the work of the Human Genome Project. Now, besides bioresearch applications, Perki…
Middleware Provides Opportunity For Labs to Gain New Functions
“Even as more laboratories begin to use middleware, the number of functions and uses for middleware continues to increase —Gregory R Vail, CEO, Data Innovations, Inc. CEO SUMMARY: Middleware is attracting attention throughout the laboratory ind…
Spectrum Lab Network Is Sold to Equity Investor
CEO SUMMARY: Timing of the sale of Spectrum Laboratory Network to Apax Partners, L.P. was unexpected, but it’s been known for some time that the fast-growing regional laboratory was entertaining purchase offers. Under new ownership and with ready access to ample capital, Spectrum is optimis…
WSJ Slams Client Bill For Lab Test Services
CEO SUMMARY: In a front-page story last Friday, the Wall Street Journal published an investigative story on the topic of client billing for laboratory testing and anatomic pathology services. It’s a “must-read” story for all pathologists and lab managers. For years, the lab industry…
Proteomic Tests Poised For Clinical Market
CEO SUMMARY: Proteomics-based technology is developing rapidly. The strategic collaboration announced last month between Ciphergen Biosystems and Quest Diagnostics Incorporated is potentially worth $25 million. It is an expensive bet that next-generation proteomics tests soon to enter the…
Phlebotomists in Calif. Undergoing Certification
CEO SUMMARY: State certification of phlebotomists is under way in the Golden State. By April 9, 2006, all phlebotomists in California will need to maintain state certification. This development adds complexity to laboratory management in California. However, there are no signs that other …
CURRENT ISSUE
Volume XXXII, No. 12 – August 25, 2025
In an exclusive interview, a laboratory industry M&A specialist discusses what’s driving lab outreach sales to national lab companies. Also, The Dark Report analyzes ways in which pathology and clinical labs can profitably partner with pharmaceutical companies.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.